Eden vs ShedRx
Two GLP-1 desks, one scoreboard. We put Eden and ShedRx head-to-head on the published Brief Score — the same six factors, scored the same way.
Eden
FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.
The verdict
Eden takes this head-to-head.
Eden scores 91 to 87 on our six-factor Brief Score — A polished, high-disclosure program with strong nationwide coverage — you pay more, but you know exactly what you're paying for.
That doesn't make ShedRx a bad call — it's best for readers who want an oral or sublingual option, or one of the lower tirzepatide prices on the tracker. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Eden | ShedRx | |
|---|---|---|
| Brief Score | 91/100 (A−) | 87/100 (B+) |
| Semaglutide | $239/mo | $199/mo on the 1-month plan · $179/mo on 6 months · $159/mo only on a 12-month commitment (all plans carry a 2-month minimum) |
| Tirzepatide | $349/mo | $299/mo on the 1-month plan · $269/mo on 6 months · $239/mo only on a 12-month commitment (all plans carry a 2-month minimum) |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Fallingprice falling |
Eden: Premium line steady; high supply-chain disclosure keeps our confidence high.
ShedRx: Its $239 tirzepatide is the lowest rate among our partners, but only on the 12-month commitment — the 1-month rung is $299.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.